Clinical Trial Update: An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study [Phase 4]

View source ↗

Summary

Phase 4 open-label add-on trial evaluating extended-release clonidine as an anti-manic agent in bipolar disorder; the study was terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: Mclean Hospital | Conditions: Bipolar Disorder, Mania | Phase 4 | Status: TERMINATED | Results posted: 2017-04-26